Mallinckrodt Rx Business Is Spin-Off Candidate After Tyco Merger
Executive Summary
Mallinckrodt's imaging agent and bulk pharmaceutical businesses are spin-off candidates following the company's acquisition by Tyco International.
You may also be interested in...
DuPont Spinning Off Rx Business As Cozaar Profit-Share Trigger Nears
DuPont's handling of the profit-sharing agreement for Cozaar is a central consideration in the valuing of the company's planned prescription drug spin-off.
DuPont Spinning Off Rx Business As Cozaar Profit-Share Trigger Nears
DuPont's handling of the profit-sharing agreement for Cozaar is a central consideration in the valuing of the company's planned prescription drug spin-off.
Palatin LeuTech Diagnostic Cost-Effectiveness Analysis Under Way
Palatin Technologies is conducting a cost-effectiveness analysis to support use of LeuTech to aid in the diagnosis of equivocal appendicitis.